Clinical Trials Logo

Clinical Trial Summary

This is a monocentric prospective, randomized, double-blind placebo-controlled study. It is designed to evaluate the superiority of the rTMS over sham treatment of depressive symptoms in the context of dementia. It is aimed at a population ≥ 65 years old, with affective BPSD. We wish to recruit 44 participants, with an estimated rate of potential drop out of 20%. Patients will be randomly assigned to the sham or rTMS group. The sham stimulation reproduces the procedure in all the steps, has the same duration and differs exclusively by the device setting. After inclusion, both groups will receive 15 sessions distributed over 5 days a week for 3 weeks


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05262868
Study type Interventional
Source Centre Hospitalier Universitaire Vaudois
Contact
Status Active, not recruiting
Phase Phase 4
Start date January 1, 2022
Completion date January 31, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03451760 - Feru-guard for Behavioral Symptoms in Dementia Phase 2
Recruiting NCT03297268 - Behavioral and Environmental Sensing and Intervention N/A
Withdrawn NCT04288193 - Implementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the PACE Setting: A Pilot Study
Completed NCT05034107 - Effects of Diffused Ylang-Ylang Essential Oil Amongst Older Persons With Dementia N/A
Recruiting NCT05977855 - Use of a Diary to Assess and Monitor Behavioral and Psychological Symptoms of Dementia ( BPSDiary ) N/A
Completed NCT03692182 - The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)
Completed NCT05508646 - Group-Based Telehealth Music Therapy Intervention for Patients With Dementia: A Pilot Study N/A
Active, not recruiting NCT05749939 - Acceptance Commitment Therapy for Caregivers of People With Memory Loss Phase 3
Withdrawn NCT05275257 - Can the Use of Uricap Female Device Lead to Better Care for Women > 75+Years? N/A